Log In
BCIQ
Print this Print this
 

MoxDuo IV (Q8012 Intravenous)

  Manage Alerts
Collapse Summary General Information
Company QRxPharma Ltd.
DescriptionIntravenous (IV) dual opioid formulation of morphine and oxycodone
Molecular Target Mu opioid receptor (MOR) (OPRM1)
Mechanism of Action 
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentPhase II
Standard IndicationPain
Indication DetailsFirst line therapy for acute moderate to severe hospital-based pain
Regulatory Designation
PartnerAoxing Pharmaceutical Co. Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today